Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention

<i>Background and Objectives</i>: Remote ischemic preconditioning (RIPC) has demonstrated efficacy in protecting against myocardial ischemia–reperfusion injury when applied before percutaneous coronary revascularization. Ranolazine, an anti-ischemic drug, has been utilized to minimize ischemic event...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Konstantinos Kourtis, Angeliki Bourazana, Andrew Xanthopoulos, Spyridon Skoularigkis, Emmanouil Papadakis, Sotirios Patsilinakos, John Skoularigis
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2024-01-01
Rangatū:	Medicina
Ngā marau:	ranolazine preconditioning cardioprotection percutaneous coronary intervention
Urunga tuihono:	https://www.mdpi.com/1648-9144/60/1/166
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!